Biocon’s Q1FY25 Results: A Record-Breaking Surge in Profits and Revenue
- August 9, 2024
Biocon, a leading player in the biopharmaceutical industry, has announced impressive financial results for Q1FY25, showcasing a remarkable 550% surge in net profit and a significant 30% increase in revenue. Key Financial
